<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>11</volume><submitter>Kwon Y</submitter><pubmed_abstract>&lt;h4>Objective&lt;/h4>Biliary atresia (BA) patients develop chronic liver disease after the Kasai operation and are eventually indicated for liver transplantation (LT). The purposes of this study were to analyze long-term outcomes after LT and risk factors that affect complications to reduce graft failure.&lt;h4>Study design&lt;/h4>Overall, 145 pediatric patients who underwent LT between June 1996 and June 2020 after a diagnosis of BA were included. We performed a retrospective analysis of medical records and evaluated patient and graft survival, cumulative incidence of complications, risk factors, and the results of policy changes.&lt;h4>Results&lt;/h4>Patient and graft survival rates in over 20 years were 95.8% and 91.0%, respectively. Post-transplantation lymphoproliferative disease was frequently observed in the early period of immunosuppression within the first 1-2 years after LT. The incidence of cholangitis and rejection steadily increased over time. Weight-to-portal vein size was evaluated as a risk factor for cholangitis and bile duct strictures (OR = 12.82, &lt;i>p&lt;/i> = 0.006 and OR = 16.54, &lt;i>p&lt;/i> = 0.015, respectively). When evaluated using 2013 as a reference point, the split graft indication was expanded and the group that received LT after 2013 had a significantly lower survival over time compared with that of the group that received LT before 2013 (&lt;i>p&lt;/i> = 0.006).&lt;h4>Conclusion&lt;/h4>This study revealed time differences in prevalence of complications. The evaluation of weight-to-duct or vessel size is a more important factor in considering complications than the graft-to-recipient weight ratio. Survival outcomes may have been altered by a policy change that affects the donor type ratio in transplantation.</pubmed_abstract><journal>Frontiers in pediatrics</journal><pagination>1242009</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10940458</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Long-term outcomes of liver transplantation for biliary atresia and results of policy changes: over 20 years of follow-up experience.</pubmed_title><pmcid>PMC10940458</pmcid><pubmed_authors>Choe YH</pubmed_authors><pubmed_authors>Lee S</pubmed_authors><pubmed_authors>Yang J</pubmed_authors><pubmed_authors>Kwon Y</pubmed_authors><pubmed_authors>Kim ES</pubmed_authors><pubmed_authors>Kim MJ</pubmed_authors><pubmed_authors>Ahn YJ</pubmed_authors></additional><is_claimable>false</is_claimable><name>Long-term outcomes of liver transplantation for biliary atresia and results of policy changes: over 20 years of follow-up experience.</name><description>&lt;h4>Objective&lt;/h4>Biliary atresia (BA) patients develop chronic liver disease after the Kasai operation and are eventually indicated for liver transplantation (LT). The purposes of this study were to analyze long-term outcomes after LT and risk factors that affect complications to reduce graft failure.&lt;h4>Study design&lt;/h4>Overall, 145 pediatric patients who underwent LT between June 1996 and June 2020 after a diagnosis of BA were included. We performed a retrospective analysis of medical records and evaluated patient and graft survival, cumulative incidence of complications, risk factors, and the results of policy changes.&lt;h4>Results&lt;/h4>Patient and graft survival rates in over 20 years were 95.8% and 91.0%, respectively. Post-transplantation lymphoproliferative disease was frequently observed in the early period of immunosuppression within the first 1-2 years after LT. The incidence of cholangitis and rejection steadily increased over time. Weight-to-portal vein size was evaluated as a risk factor for cholangitis and bile duct strictures (OR = 12.82, &lt;i>p&lt;/i> = 0.006 and OR = 16.54, &lt;i>p&lt;/i> = 0.015, respectively). When evaluated using 2013 as a reference point, the split graft indication was expanded and the group that received LT after 2013 had a significantly lower survival over time compared with that of the group that received LT before 2013 (&lt;i>p&lt;/i> = 0.006).&lt;h4>Conclusion&lt;/h4>This study revealed time differences in prevalence of complications. The evaluation of weight-to-duct or vessel size is a more important factor in considering complications than the graft-to-recipient weight ratio. Survival outcomes may have been altered by a policy change that affects the donor type ratio in transplantation.</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023</publication><modification>2026-06-26T03:09:41.814Z</modification><creation>2026-06-26T03:07:58.993Z</creation></dates><accession>S-EPMC10940458</accession><cross_references><pubmed>38495838</pubmed><doi>10.3389/fped.2023.1242009</doi></cross_references></HashMap>